AAPL336.67+3.04 (+0.91%) ▲|ABBV271.36+4.67 (+1.75%) ▲|ABT98.73+0.57 (+0.58%) ▲|ACN196.64+3.24 (+1.68%) ▲|ADBE232.77-5.35 (-2.25%) ▼|AMAT520.65-9.62 (-1.81%) ▼|AMD645.86-3.56 (-0.55%) ▼|AMGN413.08+10.48 (+2.60%) ▲|AMT166.18+1.40 (+0.85%) ▲|AMZN259.92+3.63 (+1.42%) ▲|AVGO376.51+0.70 (+0.19%) ▲|AXP304.25-0.30 (-0.10%) ▼|BA188.32-1.50 (-0.79%) ▼|BAC53.52-0.57 (-1.05%) ▼|BKNG155.87-1.76 (-1.12%) ▼|BLK1,069.63-9.79 (-0.91%) ▼|BMY59.70+0.11 (+0.18%) ▲|BNY142.72-1.01 (-0.70%) ▼|BRK-B506.25+0.71 (+0.14%) ▲|C127.32-1.20 (-0.93%) ▼|CAT813.83-49.61 (-5.75%) ▼|CL87.21-0.04 (-0.05%) ▼|CMCSA20.94-0.29 (-1.37%) ▼|COF195.91+0.09 (+0.05%) ▲|COP129.84+0.49 (+0.38%) ▲|COST942.25+6.57 (+0.70%) ▲|CRM224.56-0.43 (-0.19%) ▼|CSCO117.39-0.55 (-0.47%) ▼|CVS87.95+1.52 (+1.76%) ▲|CVX205.15-2.43 (-1.17%) ▼|DE656.87-25.92 (-3.80%) ▼|DHR218.49+2.88 (+1.34%) ▲|DIS104.75+0.72 (+0.69%) ▲|DUK115.50-0.16 (-0.14%) ▼|EMR159.22-2.18 (-1.35%) ▼|FDX289.04+0.01 (+0.00%) ▲|GD326.63-4.70 (-1.42%) ▼|GE303.62-5.77 (-1.87%) ▼|GEV997.09-32.12 (-3.12%) ▼|GILD146.85+2.62 (+1.82%) ▲|GM80.99-1.02 (-1.24%) ▼|GOOG347.37+2.78 (+0.81%) ▲|GOOGL350.50+2.82 (+0.81%) ▲|GS887.21-9.97 (-1.11%) ▼|HD285.77-0.92 (-0.32%) ▼|HON208.11-4.76 (-2.24%) ▼|IBM220.51-0.78 (-0.35%) ▼|INTC113.12+0.62 (+0.55%) ▲|INTU297.24+7.43 (+2.56%) ▲|ISRG414.52+9.76 (+2.41%) ▲|JNJ258.45+3.67 (+1.44%) ▲|JPM329.58-1.70 (-0.51%) ▼|KO85.82-0.35 (-0.41%) ▼|LIN483.98-5.97 (-1.22%) ▼|LLY1,188.72+31.23 (+2.70%) ▲|LMT499.22-10.90 (-2.14%) ▼|LOW181.54-2.13 (-1.16%) ▼|LRCX329.51-4.42 (-1.32%) ▼|MA570.06+3.48 (+0.61%) ▲|MCD230.88-1.57 (-0.68%) ▼|MDLZ59.38-0.24 (-0.40%) ▼|MDT85.51-1.58 (-1.81%) ▼|META721.31-17.57 (-2.38%) ▼|MMM162.12-1.52 (-0.93%) ▼|MO69.38+0.83 (+1.21%) ▲|MRK142.79+0.85 (+0.60%) ▲|MS189.71-1.31 (-0.69%) ▼|MSFT529.76+0.46 (+0.09%) ▲|MU1,088.00+42.44 (+4.06%) ▲|NEE77.06-0.82 (-1.05%) ▼|NFLX69.70+1.01 (+1.47%) ▲|NKE34.36-0.25 (-0.72%) ▼|NOW137.87-0.10 (-0.07%) ▼|NVDA237.47-1.77 (-0.74%) ▼|ORCL143.56-1.21 (-0.84%) ▼|PEP123.73-1.98 (-1.58%) ▼|PFE28.00+0.50 (+1.82%) ▲|PG147.82-0.59 (-0.40%) ▼|PLTR194.12+2.05 (+1.07%) ▲|PM192.69+2.29 (+1.20%) ▲|QCOM177.12-3.91 (-2.16%) ▼|RTX180.26-3.03 (-1.65%) ▼|SBUX93.58-2.53 (-2.63%) ▼|SCHW95.58-1.22 (-1.26%) ▼|SO85.44+0.00 (+0.00%) ▲|SPG197.59-4.15 (-2.06%) ▼|T24.47+0.04 (+0.16%) ▲|TMO662.06+5.48 (+0.83%) ▲|TMUS167.65+1.72 (+1.04%) ▲|TSLA377.81-2.87 (-0.75%) ▼|TXN288.98-8.25 (-2.78%) ▼|UBER68.45-0.63 (-0.91%) ▼|UNH375.98-0.34 (-0.09%) ▼|UNP274.68-1.93 (-0.70%) ▼|UPS92.29-0.82 (-0.88%) ▼|USB56.17-1.12 (-1.96%) ▼|V372.10+1.46 (+0.39%) ▲|VZ45.77-0.21 (-0.46%) ▼|WFC80.26-1.25 (-1.53%) ▼|WMT108.16+0.96 (+0.90%) ▲|XOM164.05-0.43 (-0.26%) ▼|AAPL336.67+3.04 (+0.91%) ▲|ABBV271.36+4.67 (+1.75%) ▲|ABT98.73+0.57 (+0.58%) ▲|ACN196.64+3.24 (+1.68%) ▲|ADBE232.77-5.35 (-2.25%) ▼|AMAT520.65-9.62 (-1.81%) ▼|AMD645.86-3.56 (-0.55%) ▼|AMGN413.08+10.48 (+2.60%) ▲|AMT166.18+1.40 (+0.85%) ▲|AMZN259.92+3.63 (+1.42%) ▲|AVGO376.51+0.70 (+0.19%) ▲|AXP304.25-0.30 (-0.10%) ▼|BA188.32-1.50 (-0.79%) ▼|BAC53.52-0.57 (-1.05%) ▼|BKNG155.87-1.76 (-1.12%) ▼|BLK1,069.63-9.79 (-0.91%) ▼|BMY59.70+0.11 (+0.18%) ▲|BNY142.72-1.01 (-0.70%) ▼|BRK-B506.25+0.71 (+0.14%) ▲|C127.32-1.20 (-0.93%) ▼|CAT813.83-49.61 (-5.75%) ▼|CL87.21-0.04 (-0.05%) ▼|CMCSA20.94-0.29 (-1.37%) ▼|COF195.91+0.09 (+0.05%) ▲|COP129.84+0.49 (+0.38%) ▲|COST942.25+6.57 (+0.70%) ▲|CRM224.56-0.43 (-0.19%) ▼|CSCO117.39-0.55 (-0.47%) ▼|CVS87.95+1.52 (+1.76%) ▲|CVX205.15-2.43 (-1.17%) ▼|DE656.87-25.92 (-3.80%) ▼|DHR218.49+2.88 (+1.34%) ▲|DIS104.75+0.72 (+0.69%) ▲|DUK115.50-0.16 (-0.14%) ▼|EMR159.22-2.18 (-1.35%) ▼|FDX289.04+0.01 (+0.00%) ▲|GD326.63-4.70 (-1.42%) ▼|GE303.62-5.77 (-1.87%) ▼|GEV997.09-32.12 (-3.12%) ▼|GILD146.85+2.62 (+1.82%) ▲|GM80.99-1.02 (-1.24%) ▼|GOOG347.37+2.78 (+0.81%) ▲|GOOGL350.50+2.82 (+0.81%) ▲|GS887.21-9.97 (-1.11%) ▼|HD285.77-0.92 (-0.32%) ▼|HON208.11-4.76 (-2.24%) ▼|IBM220.51-0.78 (-0.35%) ▼|INTC113.12+0.62 (+0.55%) ▲|INTU297.24+7.43 (+2.56%) ▲|ISRG414.52+9.76 (+2.41%) ▲|JNJ258.45+3.67 (+1.44%) ▲|JPM329.58-1.70 (-0.51%) ▼|KO85.82-0.35 (-0.41%) ▼|LIN483.98-5.97 (-1.22%) ▼|LLY1,188.72+31.23 (+2.70%) ▲|LMT499.22-10.90 (-2.14%) ▼|LOW181.54-2.13 (-1.16%) ▼|LRCX329.51-4.42 (-1.32%) ▼|MA570.06+3.48 (+0.61%) ▲|MCD230.88-1.57 (-0.68%) ▼|MDLZ59.38-0.24 (-0.40%) ▼|MDT85.51-1.58 (-1.81%) ▼|META721.31-17.57 (-2.38%) ▼|MMM162.12-1.52 (-0.93%) ▼|MO69.38+0.83 (+1.21%) ▲|MRK142.79+0.85 (+0.60%) ▲|MS189.71-1.31 (-0.69%) ▼|MSFT529.76+0.46 (+0.09%) ▲|MU1,088.00+42.44 (+4.06%) ▲|NEE77.06-0.82 (-1.05%) ▼|NFLX69.70+1.01 (+1.47%) ▲|NKE34.36-0.25 (-0.72%) ▼|NOW137.87-0.10 (-0.07%) ▼|NVDA237.47-1.77 (-0.74%) ▼|ORCL143.56-1.21 (-0.84%) ▼|PEP123.73-1.98 (-1.58%) ▼|PFE28.00+0.50 (+1.82%) ▲|PG147.82-0.59 (-0.40%) ▼|PLTR194.12+2.05 (+1.07%) ▲|PM192.69+2.29 (+1.20%) ▲|QCOM177.12-3.91 (-2.16%) ▼|RTX180.26-3.03 (-1.65%) ▼|SBUX93.58-2.53 (-2.63%) ▼|SCHW95.58-1.22 (-1.26%) ▼|SO85.44+0.00 (+0.00%) ▲|SPG197.59-4.15 (-2.06%) ▼|T24.47+0.04 (+0.16%) ▲|TMO662.06+5.48 (+0.83%) ▲|TMUS167.65+1.72 (+1.04%) ▲|TSLA377.81-2.87 (-0.75%) ▼|TXN288.98-8.25 (-2.78%) ▼|UBER68.45-0.63 (-0.91%) ▼|UNH375.98-0.34 (-0.09%) ▼|UNP274.68-1.93 (-0.70%) ▼|UPS92.29-0.82 (-0.88%) ▼|USB56.17-1.12 (-1.96%) ▼|V372.10+1.46 (+0.39%) ▲|VZ45.77-0.21 (-0.46%) ▼|WFC80.26-1.25 (-1.53%) ▼|WMT108.16+0.96 (+0.90%) ▲|XOM164.05-0.43 (-0.26%) ▼|
14.5 C
New York
Thursday, October 8, 2026

Tag: company

newssourceFORcompanyinformationcontent1releasesmarket

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter financial results before the market opens on Friday, August 1, 2025. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, today announced that its randomized, double-blind, placebo-controlled Phase 2b clinical trial evaluating inidascamine (formerly RL-007) in patients with cognitive impairment associated with schizophrenia (CIAS) did not meet its primary endpoint.

Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer

MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the Company will hold a conference call and webcast on Monday, July 28, 2025 at 8:00 AM ET to disclose the topline results of the PIK3CA Wild-Type Cohort from the Phase 3 VIKTORIA-1 trial.

NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups

Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November 
Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November

Matrix Medical Network Announces Strategic Partnership with Molecular Testing Labs to Enhance In-Home Diagnostic Offerings

Leader In Delivering Home-Based Health and Care Services Partners with Laboratory Known for Quality, Reliability and Innovation NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Matrix Medical...

Kirby McInerney LLP Announces Investigation Against Barnes & Noble Education, Inc. (BNED) on Behalf of Investors

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Barnes & Noble Education, Inc. (“Barnes & Noble” or the “Company”) (NYSE: BNED). The investigation concerns whether Barnes and Noble and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

Hubbell Incorporated Reports Regular Quarterly Dividend

Shelton, CT, July 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today declared a regular quarterly dividend of $1.32 per share on the Company’s common stock. The dividend will be paid September 15, 2025 to shareholders of record on August 29, 2025. 

CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Capricorn Therapeutics, Inc. (CAPR) Misled Investors Regarding the Viability of Deramiocel

Best Kratom? Super Speciosa Relaunches Enhanced Watermelon Kratom Tincture in 2025

As Consumer Demand Surges for Lab-Tested Botanical Products, Super Speciosa Responds With a Timely Tincture Update and GMP-Backed Transparency 
As Consumer Demand Surges for Lab-Tested Botanical Products, Super Speciosa Responds With a Timely Tincture Update and GMP-Backed Transparency

POP BIO and CEPI announce collaboration for faster responses to Disease X

Buffalo, NY, July 25, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a biotechnology company specializing in nanoparticle-based vaccines, and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a new collaboration to accelerate the development of vaccines against future pandemic threats, including a potential ‘Disease X’. Backed by up to $1.5 million in funding from CEPI, the partnership will advance POP BIO’s SNAP™ (Spontaneous Nanoliposome Antigen Particleization) platform—a plug-and-play technology designed to enable rapid-response vaccine development through streamlined protein purification and nanoparticle delivery.

Canadian Investment Regulatory Organization Trading Halt – BOCA

VANCOUVER, BC, July 25, 2025 /CNW/ - The following issues have been halted by CIRO Company: Bocana Resources Corp. TSX-Venture Symbol: BOCA All Issues: Yes Reason: Pending News Halt Time...

Everlight Solar Named Milwaukee’s Top Choice Winner

MILWAUKEE, July 24, 2025 /PRNewswire/ -- Everlight Solar is honored to announce its recognition as a Milwaukee Top Choice winner for 2025. This community-powered...

Vesper Holdings and Fortress Investment Group Recapitalize Hawks Pointe at the University of Kansas

Vesper Holdings and Fortress Investment Group Recapitalize Hawks Pointe, a 463-bed student housing community at the University of Kansas 
Vesper Holdings and Fortress Investment Group Recapitalize Hawks Pointe, a 463-bed student housing community at the University of Kansas

Spear AI Secures Seed Funding from Scare the Bear Capital and Cortical Ventures to Accelerate Maritime AI Solutions and Expand Technical Services

WASHINGTON, July 25, 2025 /PRNewswire/ -- Spear AI, a leading developer of maritime artificial intelligence solutions, today announced the successful completion of its seed funding...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers